| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/07/1991 | EP0439542A1 Filamentous hemagglutinin of b. pertussis |
| 08/07/1991 | EP0439508A1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 08/07/1991 | EP0439502A1 A purification process for covalently bound dna/protein complexes |
| 08/07/1991 | CN1053642A 传染性支气管炎病毒疫苗 Infectious bronchitis virus vaccine |
| 08/07/1991 | CA2073766A1 Cyclic gnrh antagonists |
| 08/06/1991 | US5037960 Inhibitor of protein synthesis, process for its isolation, its use and pharmaceutical compositions in which it is present |
| 08/06/1991 | US5037959 Purified glycoprotein isolated from Solanaceae |
| 08/06/1991 | US5037958 Immunosuppressive factor |
| 08/06/1991 | US5037957 Cysteine proteinase inhibitor |
| 08/06/1991 | US5037806 Biologically active method using somatotropins |
| 08/06/1991 | US5037805 Administering follicle stimulating hormone inhibiting protein; endometriosis |
| 08/06/1991 | US5037803 Product comprising a silicon organic compound combined with a cosmetically active substance |
| 08/06/1991 | US5037753 Feline t-lymphotropic lentivirus |
| 08/06/1991 | US5037744 Process for the microbiological preparation of human serum albumin |
| 08/06/1991 | US5037743 Heterologous proteins; genetic engineering |
| 08/06/1991 | US5037742 Pseudorabies virus recombinants and their use in the production of proteins |
| 08/06/1991 | US5037741 Dipeptides such as aspartame, diffusion across an ion-rejection membrane |
| 08/06/1991 | US5037644 Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| 08/06/1991 | US5037643 Cosmetic composition |
| 08/06/1991 | CA2035691A1 Process for preparing human factor viii and analogs of factor viii |
| 08/06/1991 | CA1287311C Recombinant dna provided with hepatitis b virus gene, mammalian cells transformed with cloned viral dna, and production of hepatitis b virus proteins |
| 08/04/1991 | WO1991011520A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES |
| 08/03/1991 | WO1991011529A1 Monoclonal antibodies which differentiate between native and modified sequence proteins |
| 08/03/1991 | WO1991011460A1 Hepatitis a vaccines |
| 08/03/1991 | WO1991011458A1 CYCLIC PEPTIDES CONTAINING Arg-Gly-Asp FLANKED BY PROLINE |
| 08/03/1991 | WO1991011197A1 New method for treating immunodeficiency or neutropenia |
| 08/03/1991 | CA2075191A1 Method for treating immunodeficiency or neutropenia |
| 08/03/1991 | CA2075038A1 Monoclonal antibodies which differentiate between native and modified sequence proteins |
| 08/03/1991 | CA2073696A1 Cyclic peptides containing arg-gly-asp flanked by proline |
| 08/03/1991 | CA2035386A1 Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses |
| 08/02/1991 | WO1991011464A1 Lipopolysaccharide binding opsonin and methods of use thereof |
| 08/02/1991 | WO1991011190A1 Self-inactivating bird vector |
| 08/02/1991 | CA2075298A1 Lipopolysaccharide binding opsonin and methods of use thereof |
| 08/02/1991 | CA2075067A1 Auto-inactivating aviary vector |
| 08/02/1991 | CA2035332A1 Extraction selective prepurification process for proteins contained in dairly products |
| 08/01/1991 | WO1991011718A1 Assays and treatments for autoimmune diseases |
| 08/01/1991 | WO1991011523A1 Strain ral-4, useful for production of small proteins and peptides |
| 08/01/1991 | WO1991011198A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 08/01/1991 | CA2074525A1 Assays and treatments for autoimmune diseases |
| 08/01/1991 | CA2073963A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 08/01/1991 | CA2070994A1 Ral-4, useful in the production of small proteins and peptides |
| 08/01/1991 | CA2035303A1 Tripeptidase |
| 08/01/1991 | CA2035200A1 Antibodies specifically recognizing somatotropin binding protein |
| 08/01/1991 | CA2035199A1 Temperature-stable becillus thuringiensis toxin |
| 08/01/1991 | CA2035163A1 Method for treating renal disease |
| 07/31/1991 | WO1991011462A2 Merosin, nucleic acids encoding, fragments and uses thereof |
| 07/31/1991 | EP0439442A2 Factor x-laci hybrid protein |
| 07/31/1991 | EP0439174A2 Inhibition of gut endothelium ion-secretion by peptide derivatives |
| 07/31/1991 | EP0439095A2 Therapeutic antibody based fusion proteins |
| 07/31/1991 | EP0439077A2 Synthetic peptide compositions with immunoreactivities to antibodies to HTLV |
| 07/31/1991 | EP0439056A2 Coccidiosis vaccines |
| 07/31/1991 | EP0438873A1 Inhibitor of ribonucleotide reductase of herpes viruses |
| 07/31/1991 | EP0438581A1 Cell lineages infectable by a retrovirus and containing a marker activated by the infection |
| 07/31/1991 | EP0438519A1 Therapeutic peptides |
| 07/31/1991 | EP0408625A4 Diagnosis of mycobacterium bovis infection |
| 07/31/1991 | EP0215126B1 Human granulocyte colony stimulating factor |
| 07/31/1991 | CN1053445A Isolation of alpha 1-antitrypsin from human plasma and construction of kit useful for detecting alpha 1-antitrypsin levels in blood |
| 07/31/1991 | CA2074361A1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 07/30/1991 | WO1991011514A1 Anticoagulant proteins |
| 07/30/1991 | USRE33653 Relpacement of cysteine with other amino acid; crosslinking inhibition |
| 07/30/1991 | US5036056 Methods for treating damaged corneal, uterine, or cartilage tissue |
| 07/30/1991 | US5036053 Diol-containing renin inhibitors |
| 07/30/1991 | US5036003 Antibodies to VPF |
| 07/30/1991 | US5036002 Expression system with trans-acting DNA segments |
| 07/30/1991 | US5035901 Bone growth |
| 07/30/1991 | US5035887 Wound healing composition of IL-1 and PDGF or IGF-1 |
| 07/30/1991 | US5035878 Reversing bone marrow damage resulting from chemotherapy |
| 07/30/1991 | CA1286989C Immunoamplifiers and related compositions |
| 07/27/1991 | WO1991011528A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | WO1991011519A1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process |
| 07/27/1991 | WO1991011461A1 C4 binding protein fusion proteins |
| 07/27/1991 | WO1991011199A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2074512A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2073859A1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process |
| 07/27/1991 | CA2073459A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2049964A1 C4 binding protein fusion proteins |
| 07/27/1991 | CA2034768A1 Recombinant coccidiosis vaccines - 5-7 eimeria surface antigen |
| 07/26/1991 | WO1991011193A1 Method and compositions for inhibiting angiogenesis |
| 07/26/1991 | CA2074725A1 Method and compositions for inhibiting angiogenesis |
| 07/25/1991 | WO1991011532A1 Diagnosis of hereditary retinal degenerative diseases |
| 07/25/1991 | WO1991011194A1 Lfa-3 as a vaccine adjuvant |
| 07/25/1991 | WO1991010738A1 T cell growth factor |
| 07/25/1991 | WO1991010736A2 CLONING AND CHARACTERIZATION OF THE CD3θ SUBUNIT |
| 07/25/1991 | WO1991010735A2 Human receptor of tsh. sequence coding for such receptor |
| 07/25/1991 | WO1991010734A1 Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 07/25/1991 | WO1991010727A1 Inhibitors of cell regulatory factors |
| 07/25/1991 | WO1991010725A1 Fertile transgenic corn plants |
| 07/25/1991 | WO1991010724A1 Preparation exhibiting enzymatic delignification activity, a method of producing the same, and applications thereof |
| 07/25/1991 | WO1991010722A2 Chimeric immunoglobulin for cd4 receptors |
| 07/25/1991 | WO1991010682A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof |
| 07/25/1991 | WO1991010680A1 Tumor killing effects of enterotoxins and related compounds |
| 07/25/1991 | WO1991010676A1 Peptides utilizable for immunomodulation |
| 07/25/1991 | WO1991010671A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/25/1991 | WO1991010453A1 Vector with multiple target response elements affecting gene expression |
| 07/25/1991 | WO1991010443A1 Immunosuppressive compositions and methods of use |
| 07/25/1991 | WO1991010442A1 Hiv protease inhibitors |
| 07/25/1991 | WO1991010438A1 Soluble t-cell antigen receptor chimeric antigens |
| 07/25/1991 | WO1991010426A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/25/1991 | WO1991010369A1 Method for preparing an enzymatic hydrolyzate |
| 07/25/1991 | WO1991010363A1 Agricultural-chemical-producing endosymbiotic microorganisms |